This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1993 Dec 11;307(6918):1505-6.

doi: 10.1136/bmj.307.6918.1505.

Acromegaly: treatment after 100 years

J A Wass

PMID: 8274912
PMCID: PMC1679591
DOI: 10.1136/bmj.307.6918.1505

Editorial

Acromegaly: treatment after 100 years

J A Wass. BMJ. 1993.

. 1993 Dec 11;307(6918):1505-6.

doi: 10.1136/bmj.307.6918.1505.

Author

J A Wass

PMID: 8274912
PMCID: PMC1679591
DOI: 10.1136/bmj.307.6918.1505

No abstract available

PubMed Disclaimer

Similar articles

Growth hormone levels in acromegaly after external radiotherapy.
Grayzel EF. Grayzel EF. Arch Intern Med. 1977 Jun;137(6):808-9. Arch Intern Med. 1977. PMID: 869653
An assessment of the predictors of difficult intubation in patients with acromegaly.
Ali Z, Bithal PK, Prabhakar H, Rath GP, Dash HH. Ali Z, et al. J Clin Neurosci. 2009 Aug;16(8):1043-5. doi: 10.1016/j.jocn.2008.11.002. Epub 2009 May 19. J Clin Neurosci. 2009. PMID: 19457671
Acromegaly; a rare condition which develops insidiously.
Tunbridge WM. Tunbridge WM. Nurs Times. 1979 Jan 18;75(3):110-2. Nurs Times. 1979. PMID: 253279 No abstract available.
[Acromegaly features in the aging population].
Anoun N, El Ouahabi H. Anoun N, et al. Pan Afr Med J. 2017 Jul 4;27:169. doi: 10.11604/pamj.2017.27.169.11518. eCollection 2017. Pan Afr Med J. 2017. PMID: 28904697 Free PMC article. Review. French.
Acromegaly.
Danzig J. Danzig J. BMJ. 2007 Oct 20;335(7624):824-5. doi: 10.1136/bmj.39253.602141.AD. BMJ. 2007. PMID: 17947788 Free PMC article. Review.

See all similar articles

Cited by

The treatment of de novo acromegalic patients with octreotide-LAR: efficacy, tolerability and cardiovascular effects.
Gilbert J, Ketchen M, Kane P, Mason T, Baister E, Monaghan M, Barr S, Harris PE. Gilbert J, et al. Pituitary. 2003;6(1):11-8. doi: 10.1023/a:1026273509058. Pituitary. 2003. PMID: 14674719 Clinical Trial.
Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients.
Marzullo P, Ferone D, Di Somma C, Pivonello R, Filippella M, Lombardi G, Colao A. Marzullo P, et al. Pituitary. 1999;1(2):115-20. doi: 10.1023/a:1009932521242. Pituitary. 1999. PMID: 11081189
Growth hormone pulsatility in acromegaly following radiotherapy.
Peacey SR, Shalet SM. Peacey SR, et al. Pituitary. 1999 Jun;2(1):63-9. doi: 10.1023/a:1009974005567. Pituitary. 1999. PMID: 11081174 Review.
Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.
Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G, de Divitiis E. Cappabianca P, et al. Skull Base Surg. 1999;9(2):109-17. doi: 10.1055/s-2008-1058157. Skull Base Surg. 1999. PMID: 17171126 Free PMC article.

References

1. J Clin Endocrinol Metab. 1988 Jan;66(1):16-23 - PubMed
1. Clin Endocrinol Metab. 1986 Aug;15(3):683-707 - PubMed
1. Endocr Rev. 1988 Nov;9(4):417-36 - PubMed
1. J Clin Endocrinol Metab. 1990 Dec;71(6):1421-6 - PubMed
1. Clin Endocrinol (Oxf). 1991 Nov;35(5):379-97 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources